MDRX
Veradigm Inc. Common StockMDRX
MDRX
Delisted
MDRX was delisted on the 28th of February, 2024.
About: Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
Employees: 7,869
Financial journalist opinion
Neutral
Business Wire
2 days ago
Veradigm Launches Smart Medicine Podcast to Explore the Evolution of Healthcare
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today launched the Smart Medicine Podcast, hosted by renowned podcaster and orthopedic surgeon, Dr. Scott Sigman. The show will provide insights and inspiration for clinicians along with other healthcare professionals, as well as payer and life science industry leaders striving to navigate the complexities of modern medicine through incremental insight. The podcast features exper.
Neutral
Business Wire
2 weeks ago
Veradigm Recognized with KLAS 2025 Points of Light Award for Optimizing Value-Based Care
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, along with Metroplex Medical Centres and one of the largest healthcare payer organizations in the country, received a 2025 KLAS Points of Light Award. The case study titled, “Optimizing Value-Based Care by Delivering Insights at the Point of Care,” showcased how Veradigm and the payer integrated alerts into Metroplex Medical Centres' electronic health record (EHR) to help improve.
Neutral
Business Wire
3 weeks ago
Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation
CHICAGO--(BUSINESS WIRE)-- #CardiometabolicResearch--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today an advancement in the use of artificial intelligence (AI) to scale the generation of real-world evidence (RWE) for GLP-1 receptor agonists (GLP-1 RAs), including semaglutide and tirzepatide. By applying AI to electronic health record (EHR) deidentified data within the Veradigm Network, researchers can now surface rich, contextual insights—such as side effects, dis.
Neutral
Business Wire
1 month ago
Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payer Analytics the overall number one provider of payer analytics solutions for health plans. Veradigm has achieved this ranking for the second year in a row, also earning top marks in 2024. Veradigm Payer Analytics earned top category.
Neutral
Business Wire
2 months ago
Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Syracuse Orthopedic Specialists has selected elements from the Veradigm solution suite, Veradigm Revenue Cycle Services and Coding Services designed to support growth, improve cash flow and reduce costs. Syracuse Orthopedic Specialists, located near Syracuse, NY, provides total orthopedic care to the surrounding regions, and is currently utilizing Veradigm Re.
Neutral
Seeking Alpha
2 months ago
Veradigm Inc. (MDRX) Investor Update Call Transcript
Veradigm Inc. (OTC:MDRX) Investor Update Call March 19, 2025 8:00 AM ET Company Participants Jenny Gelinas - VP, IR Tom Langan - Interim CEO Lee Westerfield - Interim CFO Conference Call Participants Charles Rhyee - TD Cowen Jeff Garro - Stephens George Hill - Deutsche Bank Operator Greetings, and welcome to the Veradigm Investor Update Call. At this time, all participants are in a listen-only mode.
Neutral
Business Wire
2 months ago
Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership
CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX) (“Veradigm” or the “Company”), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the “Board”) appointed two new independent directors, Jonathan Sacks and Bruce Felt, to the Board, effective March 19, 2025, and that Lou Silverman will succeed Greg Garrison as Chairman upon his retirement from the Board on that date. In addition, Mr. Felt will become the Chair of the Audit Committee of th.
Neutral
Business Wire
2 months ago
Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, provided updates on financial information for fiscal 2023 and 2024 and an outlook for fiscal 2025. “We remain confident in Veradigm's business model and our value proposition,” said Tom Langan, Interim Chief Executive Officer. “We believe our core business is sound. We remain focused on remediating our material weaknesses and other internal control deficiencies, becoming current.
Neutral
Business Wire
2 months ago
Veradigm Files Fiscal 2022 Form 10-K and Restated Financial Statements
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that it filed its comprehensive Annual Report on Form 10-K for the year ended December 31, 2022, which also contains certain restated financial statements for periods in fiscal year 2022, 2021 and 2020 (the “2022 Form 10-K”), with the Securities and Exchange Commission (“SEC”). “This filing represents an important step toward regaining compliance with our financia.
Neutral
Business Wire
2 months ago
Veradigm to Release Financial Update March 18th and Host Investor Call March 19th
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a financial update after the close of regular stock market hours on March 18, 2025. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on March 19, 2025. Update Call Details Veradigm plans to distribute an announcement promptly after the close of regul.
Charts implemented using Lightweight Charts™